NO833659L - Humant immun-interferonprotein og fremgangsmaate derav - Google Patents

Humant immun-interferonprotein og fremgangsmaate derav

Info

Publication number
NO833659L
NO833659L NO833659A NO833659A NO833659L NO 833659 L NO833659 L NO 833659L NO 833659 A NO833659 A NO 833659A NO 833659 A NO833659 A NO 833659A NO 833659 L NO833659 L NO 833659L
Authority
NO
Norway
Prior art keywords
humant
immun
procedures
interferon protein
interferon
Prior art date
Application number
NO833659A
Other languages
English (en)
Other versions
NO169725C (no
NO169725B (no
Inventor
Masakazu Kikuchi
Kyozo Tsukamoto
Tsutomu Kurokawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO833659L publication Critical patent/NO833659L/no
Publication of NO169725B publication Critical patent/NO169725B/no
Publication of NO169725C publication Critical patent/NO169725C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NO833659A 1982-11-22 1983-10-07 Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein NO169725C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000445 WO1984002129A1 (fr) 1982-11-22 1982-11-22 Proteine de l'interferon immun humain et son procede de preparation

Publications (3)

Publication Number Publication Date
NO833659L true NO833659L (no) 1984-05-23
NO169725B NO169725B (no) 1992-04-21
NO169725C NO169725C (no) 1992-07-29

Family

ID=13762365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833659A NO169725C (no) 1982-11-22 1983-10-07 Fremgangsmaate for fremstilling av et uglykosylert rekombinant humant immun-interferonprotein

Country Status (18)

Country Link
EP (1) EP0110044A1 (no)
JP (4) JPS59186995A (no)
KR (1) KR920001377B1 (no)
AU (1) AU570219B2 (no)
DK (1) DK164063C (no)
ES (1) ES527414A0 (no)
FI (1) FI81832C (no)
GR (1) GR79035B (no)
HU (1) HU209152B (no)
IE (1) IE57053B1 (no)
IL (1) IL69791A (no)
MC (1) MC1553A1 (no)
NO (1) NO169725C (no)
NZ (1) NZ205667A (no)
PH (1) PH20024A (no)
PT (1) PT77573B (no)
WO (1) WO1984002129A1 (no)
ZA (1) ZA837057B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
WO1984002129A1 (fr) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Proteine de l'interferon immun humain et son procede de preparation
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
DE3426077A1 (de) * 1984-07-14 1986-01-23 Dr. Karl Thomae Gmbh, 7950 Biberach Monoklonale antikoerper gegen humanes ifn-(gamma), diese antikoerper produzierende hybridzellinien, verwendung der neuen antikoerper und verfahren zu deren herstellung
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
JPH0653067B2 (ja) * 1984-09-11 1994-07-20 武田薬品工業株式会社 新規ハイブリドーマおよびその製造法
GB2164650A (en) * 1984-09-25 1986-03-26 Fujisawa Pharmaceutical Co Process for production of y-interferon
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
US4873312A (en) * 1985-04-25 1989-10-10 Amgen Method for purifying interferon and composition of matter produced thereby
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
GB8719108D0 (en) * 1987-08-12 1987-09-16 Natural Environment Res Expression vectors
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
US7230081B1 (en) 1999-11-12 2007-06-12 Maxygen Holdings, Ltd. Interferon gamma conjugates
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
WO2004005341A2 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
CA2593964A1 (en) 2004-12-23 2006-06-29 Molmed Spa Conjugation product
CN105315323A (zh) 2007-10-30 2016-02-10 健泰科生物技术公司 通过阳离子交换层析进行的抗体纯化

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376821A (en) * 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548U (ja) * 1982-01-22 1983-07-28 株式会社東海理化電機製作所 自動車用ミラ−の駆動装置
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
WO1984002129A1 (fr) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Proteine de l'interferon immun humain et son procede de preparation
JP2526750B2 (ja) * 1991-07-30 1996-08-21 株式会社ユアサコーポレーション リチウム二次電池

Also Published As

Publication number Publication date
KR840006676A (ko) 1984-12-01
FI81832B (fi) 1990-08-31
DK164063C (da) 1992-09-28
JPS6411639B2 (no) 1989-02-27
FI81832C (fi) 1990-12-10
JPH0536414B2 (no) 1993-05-31
ES8504938A1 (es) 1985-04-16
IL69791A (en) 1994-05-30
AU1934683A (en) 1984-06-28
JPH06316532A (ja) 1994-11-15
DK164063B (da) 1992-05-04
ZA837057B (en) 1984-04-25
KR920001377B1 (ko) 1992-02-11
MC1553A1 (fr) 1984-08-31
AU570219B2 (en) 1988-03-10
NZ205667A (en) 1987-01-23
WO1984002129A1 (fr) 1984-06-07
JPS59220190A (ja) 1984-12-11
DK430683A (da) 1984-05-23
IE832216L (en) 1984-05-22
FI833525A0 (fi) 1983-09-29
IE57053B1 (en) 1992-04-08
DK430683D0 (da) 1983-09-21
ES527414A0 (es) 1985-04-16
NO169725C (no) 1992-07-29
JPS59186995A (ja) 1984-10-23
EP0110044A1 (en) 1984-06-13
PT77573B (en) 1986-03-18
GR79035B (no) 1984-10-02
HU209152B (en) 1994-03-28
PH20024A (en) 1986-09-01
FI833525L (fi) 1984-05-23
PT77573A (en) 1983-11-01
JPS63211240A (ja) 1988-09-02
NO169725B (no) 1992-04-21

Similar Documents

Publication Publication Date Title
NO801133L (no) Interferonproteiner og fremgangsmaate for fremstilling derav
DK565882A (da) Interferonpraeparater og fremgangsmaade til fremstilling heraf
BR1100036A (pt) Composto e composição farmacêutica
DK47285A (da) Renininhiberende peptider og anvendelsen deraf
DK401583A (da) Parenkymal celle-cellulose og beslaegtede materialer
DK430683D0 (da) Humant immuninterferonprotein samt dets fremstilling og anendelse
DK276683D0 (da) Carbapenemer og fremgangsmade til fremstilling deraf
DK144483A (da) Barbermaskine og barberingsenhed for barbermaskiner
NO882917D0 (no) Fusjonsproteiner og partikler.
DK557383A (da) Monoclone antistoffer og deres anvendelse
FR2550205B1 (fr) Proteines humaines, antisera et necessaires experimentaux
KR860004915A (ko) 아미노아실라브단 및 이의 제조방법
DE3486111D1 (de) Menschliches gamma-interferonpolypeptidderivat.
DK262584A (da) Interferon-gelformulering og fremgangsmaade til fremstilling heraf
DK158844C (da) Saltsyrepraeparater og anvendelse heraf
DK343183D0 (da) Ketoquinoliner og fremgangsmade til fremstilling deraf
DK196088D0 (da) Rekombinant htlv-iii protein og anvendelse deraf
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
NO863469D0 (no) Herbicid og fremgangsmaate for anvendelse derav.
DK565783D0 (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin
DK363786A (da) Hydroquinoliner og anvendelse deraf
DK238585D0 (da) Peptider og fremstilling deraf
NO924995D0 (no) Humant meg-csf-protein og fremgangsmaater
DK581383A (da) 1-carboxyalkanoylperhydroindol-2-carboxylsyrer og derivater deraf
DK125786D0 (da) Peptider og fremstilling deraf